134 related articles for article (PubMed ID: 1456740)
1. Amygdala cell loss and atrophy in Alzheimer's disease.
Scott SA; DeKosky ST; Sparks DL; Knox CA; Scheff SW
Ann Neurol; 1992 Oct; 32(4):555-63. PubMed ID: 1456740
[TBL] [Abstract][Full Text] [Related]
2. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
[TBL] [Abstract][Full Text] [Related]
3. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes.
Hamidi M; Drevets WC; Price JL
Biol Psychiatry; 2004 Mar; 55(6):563-9. PubMed ID: 15013824
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E epsilon4 is associated with atrophy of the amygdala in Alzheimer's disease.
Basso M; Gelernter J; Yang J; MacAvoy MG; Varma P; Bronen RA; van Dyck CH
Neurobiol Aging; 2006 Oct; 27(10):1416-24. PubMed ID: 16182410
[TBL] [Abstract][Full Text] [Related]
5. Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease.
Xuereb JH; Perry RH; Candy JM; Perry EK; Marshall E; Bonham JR
Brain; 1991 Jun; 114 ( Pt 3)():1363-79. PubMed ID: 2065255
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
7. Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease.
Kril JJ; Hodges J; Halliday G
Neurosci Lett; 2004 May; 361(1-3):9-12. PubMed ID: 15135880
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease.
Lehéricy S; Hirsch EC; Cervera-Piérot P; Hersh LB; Bakchine S; Piette F; Duyckaerts C; Hauw JJ; Javoy-Agid F; Agid Y
J Comp Neurol; 1993 Apr; 330(1):15-31. PubMed ID: 8468401
[TBL] [Abstract][Full Text] [Related]
9. Volumetry of amygdala and hippocampus and memory performance in Alzheimer's disease.
Basso M; Yang J; Warren L; MacAvoy MG; Varma P; Bronen RA; van Dyck CH
Psychiatry Res; 2006 Apr; 146(3):251-61. PubMed ID: 16524704
[TBL] [Abstract][Full Text] [Related]
10. Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
Emre M; Heckers S; Mash DC; Geula C; Mesulam MM
J Comp Neurol; 1993 Oct; 336(1):117-34. PubMed ID: 8254109
[TBL] [Abstract][Full Text] [Related]
11. Morphometry of the amygdala in patients with questionable dementia and mild dementia.
Hensel A; Wolf H; Dieterlen T; Riedel-Heller S; Arendt T; Gertz HJ
J Neurol Sci; 2005 Nov; 238(1-2):71-4. PubMed ID: 16112136
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal neuron and glial cell numbers in Parkinson's disease--a stereological study.
Joelving FC; Billeskov R; Christensen JR; West M; Pakkenberg B
Hippocampus; 2006; 16(10):826-33. PubMed ID: 16941622
[TBL] [Abstract][Full Text] [Related]
13. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
14. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
15. Hippocampal neurons in pre-clinical Alzheimer's disease.
West MJ; Kawas CH; Stewart WF; Rudow GL; Troncoso JC
Neurobiol Aging; 2004 Oct; 25(9):1205-12. PubMed ID: 15312966
[TBL] [Abstract][Full Text] [Related]
16. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
17. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
Teipel SJ; Flatz WH; Heinsen H; Bokde AL; Schoenberg SO; Stöckel S; Dietrich O; Reiser MF; Möller HJ; Hampel H
Brain; 2005 Nov; 128(Pt 11):2626-44. PubMed ID: 16014654
[TBL] [Abstract][Full Text] [Related]
18. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance analysis of amygdalar volume in Alzheimer's disease.
Horínek D; Varjassyová A; Hort J
Curr Opin Psychiatry; 2007 May; 20(3):273-7. PubMed ID: 17415082
[TBL] [Abstract][Full Text] [Related]
20. [Morphometric study of the magnocellular basal forebrain system in patients with Alzheimer's disease].
Kobayashi K; Fukutani Y; Nakamura I; Kawasaki Y; Suzuki M; Yamaguchi N; Nakanishi I
No To Shinkei; 1990 Apr; 42(4):345-51. PubMed ID: 2390367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
